Wegovy and other semaglutide medications have experienced periods of limited availability, making it difficult for some patients to obtain their prescriptions.[5] During the height of the shortages, healthcare providers sometimes had to adjust dosing strategies to help patients maintain treatment.[6] Novo Nordisk, the manufacturer of Wegovy and Ozempic, has reported efforts to increase production and improve supply, though demand may still exceed availability in some areas.[7] Compounded semaglutide may be more readily available in some cases and may be less expensive for certain patients
Eyer F, Felgenhauer N, Gempel K, Steimer W, Gerbitz KD, Zilker T
By activating GLP-1 receptors in the brain, it fundamentally changes the hormonal signals that drive hunger and satiety
Vitamine B1 e B5 : mantengono normali livelli di energia
Most patients report that GLP1 injections cause minimal discomfort